COVID-19 vaccine any day with an extra 1.1 million doses to be delivered by the end of March pending that approval. Several European nations are already discouraging its use among seniors, citing a lack of data.
Canada could get 1.1M more vaccine doses by March through COVAX sharing program On Friday, British regulators said they had received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine is effective in the elderly.When asked about the efficacy in older adults the day before, Canada’s deputy chief public health officer Dr.
Howard Njoo said that Health Canada will review the data as it becomes available.Earlier this week, AstraZeneca reported that a primary analysis of its Phase 3 trials showed an.